Umoja Biopharma

About:

Umoja Biopharma is a biopharmaceutical company developing next-generation immunotherapies intended to combat cancer.

Top Investors: Temasek Holdings, Cormorant Asset Management, RTW Investments, SoftBank Vision Fund, MPM Capital

Description:

Umoja Biopharma is a biopharmaceutical company developing next-generation immunotherapies intended to combat cancer. The company's treatment approach retools a patient’s immune system in vivo to direct potent anti-cancer immune cells to a patient’s tumor, augmenting the body’s natural mechanisms for fighting cancer.

Total Funding Amount:

$263M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Seattle, Washington, United States

Founded Date:

2019-01-01

Contact Email:

info(AT)umoja-biopharma.com

Founders:

Andrew Scharenberg, Philip Low, Ryan Crisman

Number of Employees:

101-250

Last Funding Date:

2021-06-15

IPO Status:

Private

Industries: